SCHEMBL25536757

SCHEMBL25536757

CCC(C(=O)O)c1ccc([C@@H](C)NC(=O)c2cc3c(Cl)c(Cl)c(OC)cc3n2C)cc1

nearest known ligand 0.57

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PHGDH O43175 20/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20768585 0.90 PHGDH (0.58) PHGDH
SCHEMBL20768586 0.90 PHGDH (0.58) PHGDH
SCHEMBL23393446 0.89 PHGDH (0.45) PHGDH
SCHEMBL19347499 0.81 PHGDH (0.58) PHGDH
SCHEMBL19343129 0.81 PHGDH (0.54) PHGDH
SCHEMBL20794390 0.81 PHGDH (0.63) PHGDH
SCHEMBL20768590 0.80 PHGDH (0.56) PHGDH
SCHEMBL19347381 0.80 PHGDH (0.56) PHGDH
SCHEMBL23393439 0.80 PHGDH (0.45) PHGDH
SCHEMBL26326966 0.79 PHGDH (0.45) PHGDH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3426244-B1 3-PHOSPHOGLYCERATE DEHYDROGENASE INHIBITORS AND USES THEREOF RAZE THERAPEUTICS INC (US) 2023-06-07 EP disclosed